SK Plasma Co., Ltd.   Report issue

For profit Phase 3
Founded: Bundang Korea, Republic of (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2016
NCT03164915
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

SK Plasma Co., Ltd.